Any current/future new fundraising through debt or equity?

There is no explicit mention of any ongoing or planned fundraising through debt or equity in the provided pages. The management emphasizes strong capital efficiency and treasury income supporting growth, indicating a focus on self-sustained funding. The company has significant cash reserves (~Rs. 500 crores combined treasury as of March 2025) and aims to use these funds for growth. A merger and demerger process is planned for the next financial year, but no direct reference to raising funds via this route. The company has conducted a buyback of Rs. 100 crores from Mitsubishi, indicating cash u

Any current/future capex/capital investment/strategic investment?

Investing ~Rs. 10 crores in West Bengal for an additional 80,000 sq ft warehouse capacity (completion in ~6 months). Planning a new warehouse in Noida; timeline about 1.5 years; also expansions in Guwahati, Lucknow, Udaipur (2-year horizon). Allocated Rs. 25 crores annually for AI and technology development for both SastaSundar and Retailer Shakti platforms. Rs. 150 crores earmarked for new technology building, with Rs. 50-60 crores already spent; remaining to be funded from treasury income over next 2-3 years. Rs. 10 crores invested in Retail Air, an AI-driven SaaS platform for retail

Future growth expectations in sales/revenue/volumes?

Retailer Shakti aims to grow at a CAGR of +30% year-on-year for the next 5-10 years, with some quarter-to-quarter variability. SastaSundar B2C business is expected to grow around 100% year-on-year from this year to next. January to March is expected to be one of the best quarters, with recent growth trends positive. Expansion plans include new warehouses in Lucknow, Udaipur, and capacity doubling in existing facilities to support growth across Eastern, Northern, and North-Eastern India. The JITO generic brand is projected to significantly increase revenue and gross margin by tapping in

Future growth expectations in earnings/operating earnings/profits/EPS?

Retailer Shakti is progressing towards EBITDA break-even by Q4 FY26 and expected to deliver sustainable EBITDA positive performance in FY27, with anticipated 1% EBITDA margin. SastaSundar B2C is progressing towards contribution margin positive in FY27 with improved operating leverage driven by higher order density and customer acquisition efficiency. The company targets around 30% year-on-year CAGR growth for Retailer Shakti over the next 5-10 years. PAT turned positive at Rs. 11 crores in 9-month FY26 vs. loss of Rs. 151 crores in the previous year, supported by improved operating efficiency

IN US

Sale is live|00:00:00left today

Health X Platform LtdQ4 FY27Healthcare Services

Health X Platform Ltd Q4 FY27 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹316P/E: 36.9Market Cap: ₹956 CrSector: Healthcare Services

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 2

→Retailer Shakti aims to grow at a CAGR of +30% year-on-year for the next 5-10 years, with some quarter-to-quarter variability.
→SastaSundar B2C business is expected to grow around 100% year-on-year from this year to next.
→January to March is expected to be one of the best quarters, with recent growth trends positive.
→Expansion plans include new warehouses in Lucknow, Udaipur, and capacity doubling in existing facilities to support growth across Eastern, Northern, and North-Eastern India.
→The JITO generic brand is projected to significantly increase revenue and gross margin by tapping into a rapidly growing generic medicine market.
→The company is confident of achieving EBITDA positive performance in Retailer Shakti by FY27 and contribution margin positivity in SastaSundar B2C by the same period.
→Overall, the company focuses on scaling revenue with improved operating efficiency and technological investments for sustainable long-term growth.

Margin guidance

Category 3

→Retailer Shakti is progressing towards EBITDA break-even by Q4 FY26 and expected to deliver sustainable EBITDA positive performance in FY27, with anticipated 1% EBITDA margin.
→SastaSundar B2C is progressing towards contribution margin positive in FY27 with improved operating leverage driven by higher order density and customer acquisition efficiency.
→The company targets around 30% year-on-year CAGR growth for Retailer Shakti over the next 5-10 years.
→PAT turned positive at Rs. 11 crores in 9-month FY26 vs. loss of Rs. 151 crores in the previous year, supported by improved operating efficiency and other income.
→January month Retailer Shakti reported EBITDA positivity, indicating a strong operational turnaround.
→Sustained focus on technology investment and expansion in categories/geographies expected to drive future operating leverage and profitability improvements starting FY27.

3 more insights locked — sign up free to unlock

Fundraise plans

→There is no explicit mention of any ongoing or planned fundraising through debt or equity in the provided pages.
→The management emphasizes strong capital efficiency and treasury income supporting growth, indicating a focus on self-sustained funding.
→The company has significant cash reserves (~Rs. 500 crores combined treasury as of March 2025) and aims to use these funds for growth.
→A merger and demerger process is planned for the next financial year, but no direct reference to raising funds via this route.
→The company has conducted a buyback of Rs. 100 crores from Mitsubishi, indicating cash utilization for shareholder returns rather than new fundraising.
→The focus remains on organic growth, technology investment, and capital-efficient expansion without explicit plans for new external funding.

Order book

The document does not explicitly mention any current or expected order book or pending orders for SastaSundar Ventures Limited. However, relevant insights related to order flow and growth include: - Retailer Shakti guarantees next-day delivery, enabling retailers to reduce inventory from 40 days to 10 days. - The company receives 100% orders through digital channels; over 50% via the app, and the rest via HealthBuddy service centers. - Q3 FY26 saw a 10% quarter-on-quarter growth, with confidence expressed in sustaining 30% CAGR over the next 5-10 years for Retailer Shakti. - SastaSundar B2C is progressing towards positive contribution margin, expecting growth driven by technology and increased retailer reach. - JITO brand sales have started recently and expected to contribute 2-3% of revenue next year, scaling to 5-10% in 3-4 years. No explicit figures on orderbook or pending orders are provided.

Capex plans

Yes

→Investing ~Rs. 10 crores in West Bengal for an additional 80,000 sq ft warehouse capacity (completion in ~6 months).
→Planning a new warehouse in Noida; timeline about 1.5 years; also expansions in Guwahati, Lucknow, Udaipur (2-year horizon).
→Allocated Rs. 25 crores annually for AI and technology development for both SastaSundar and Retailer Shakti platforms.
→Rs. 150 crores earmarked for new technology building, with Rs. 50-60 crores already spent; remaining to be funded from treasury income over next 2-3 years.
→Rs. 10 crores invested in Retail Air, an AI-driven SaaS platform for retailers, to be launched in 3-4 months.
→JITO brand distribution being scaled without additional capital outlay by leveraging existing warehouses, distribution, and technology.
→Overall capex focused on warehouse expansion, AI automation, and technology platforms to enhance supply chain and customer experience.

How does Health X Platform Ltd rank vs peers in Healthcare Services?

Pro feature

1Health X Platform Ltd

Rev 2Mar 3

See full Healthcare Services sector rankings

Want more stocks like Health X Platform Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio